Company Filing History:
Years Active: 2000-2006
Title: Joanne Bruno: Innovator in TIE-2 Ligand Research
Introduction
Joanne Bruno is a prominent inventor based in Bloomingdale, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of TIE-2 ligands. With a total of 4 patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Joanne's latest patents include innovative methods related to TIE-2 ligands. One of her notable inventions provides an isolated nucleic acid molecule encoding a human TIE-2 ligand. This invention also encompasses a receptor body that specifically binds to the human TIE-2 ligand, along with an antibody that targets the same. Furthermore, her work includes the development of an antagonist of human TIE-2, therapeutic compositions, and methods for blocking blood vessel growth. These methods aim to promote neovascularization, support the growth or differentiation of cells expressing the TIE-2 receptor, and attenuate or prevent tumor growth in humans.
Career Highlights
Joanne Bruno is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to advance her research in the field. Her innovative work has positioned her as a key figure in the biotechnology sector, contributing to the understanding and application of TIE-2 ligands in therapeutic settings.
Collaborations
Joanne collaborates with esteemed colleagues such as Samuel H. Davis and Mitchell Goldfarb. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in biotechnology.
Conclusion
Joanne Bruno's contributions to the field of TIE-2 ligands exemplify her dedication to innovation and research. Her patents and ongoing work at Regeneron Pharmaceuticals, Inc. highlight her role as a leading inventor in biotechnology.